Falling wedge on Cannabis Testing Company Abattis Bioceuticals
Updated
Falling wedge on 60m chart with basing MACD and RSI. For short and long this is a great price for this company, which has been bleeding since peak in january. PENNY STOCK Opp.
Trade active
Nice 60% climb since first posting and ready to jump another 60% in next month as testing gets ready for medical sales growth and recreational use.Note
Bought half at 0.089 and 2nd half at 0.082 and at 0.152
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.